Browse 500+ in vivo-grade antibodies formulated for preclinical animal studies. Low-endotoxin, azide-free formulations suitable for immune cell depletion, checkpoint blocking, cytokine neutralization, and receptor modulation studies. For the highest purity requirements, see our InVivo Plus line with ultra-low endotoxin (≤0.001 EU/µg). All products are designated Research Use Only (RUO) — not intended for diagnostic or therapeutic procedures. RUO
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Neutralization
Human
IgG1, kappa
Iv0221
Nipah virus (NiV)
ELISA, Neutralization
Human
IgG1, kappa
nAH1.3
Human
ELISA, Neutralization
Human
IgG1, kappa
Iv0090
Mouse
in vivo PD-L1 blockade, in vitro PD-L1 blockade, IF, IHC-F, FCM, WB
Rat
IgG2b
10F.9G2
Mouse
in vivo blocking of PD-1/PD-L signaling
Rat
IgG2a, kappa
RMP1-14
Human respiratory syncytial virus A (HRSV-A), Human respiratory syncytial virus B (HRSV-B), Human metapneumovirus (HMPV)
ELISA, Neutralization
Human
IgG1, kappa
M2B6
Human respiratory syncytial virus A (HRSV-A), Human respiratory syncytial virus B (HRSV-B), Human metapneumovirus (HMPV)
ELISA, Neutralization
Human
IgG1, kappa
M2D2
Human respiratory syncytial virus A (HRSV-A), Human respiratory syncytial virus B (HRSV-B), Human metapneumovirus (HMPV)
ELISA, Neutralization
Human
IgG1, kappa
M1C7
Human metapneumovirus (HMPV)
ELISA, Neutralization
Human
IgG1
MPV458
Human metapneumovirus (HMPV)
ELISA, Neutralization
Human
IgG1
MPV465